Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia.
Saved in:
| Title: | Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia. |
|---|---|
| Authors: | Bjelosevic S; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Fauth R; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Do BT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Harvard-MIT Health Sciences and Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Merickel LA; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Jackson TD; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA., Basanthakumar AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Taillon A; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Salhotra S; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Ryback B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA., Schneider C; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., DiGiovanni G; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Elbashir R; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA., Burger N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA., Bin Munim M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA., Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Puigserver P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.; Lead contact. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Jun 29. Date of Electronic Publication: 2025 Jun 29. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40666848 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bjelosevic+S%22">Bjelosevic S</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Fauth+R%22">Fauth R</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Do+BT%22">Do BT</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Harvard-MIT Health Sciences and Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Alexe+G%22">Alexe G</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Merickel+LA%22">Merickel LA</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Jackson+TD%22">Jackson TD</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA.<br /><searchLink fieldCode="AU" term="%22Basanthakumar+AT%22">Basanthakumar AT</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Taillon+A%22">Taillon A</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Salhotra+S%22">Salhotra S</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Ryback+B%22">Ryback B</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22DiGiovanni+G%22">DiGiovanni G</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Elbashir+R%22">Elbashir R</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Burger+N%22">Burger N</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA.<br /><searchLink fieldCode="AU" term="%22Bin+Munim+M%22">Bin Munim M</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Lin+S%22">Lin S</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Puigserver+P%22">Puigserver P</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA.<br /><searchLink fieldCode="AU" term="%22Root+DE%22">Root DE</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.<br /><searchLink fieldCode="AU" term="%22Vander+Heiden+MG%22">Vander Heiden MG</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.<br /><searchLink fieldCode="AU" term="%22Stegmaier+K%22">Stegmaier K</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.; Lead contact. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2025 Jun 29. <i>Date of Electronic Publication: </i>2025 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40666848 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2025.06.26.661633 Languages: – Code: eng Text: English Titles: – TitleFull: Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bjelosevic S – PersonEntity: Name: NameFull: Fauth R – PersonEntity: Name: NameFull: Do BT – PersonEntity: Name: NameFull: Alexe G – PersonEntity: Name: NameFull: Merickel LA – PersonEntity: Name: NameFull: Jackson TD – PersonEntity: Name: NameFull: Basanthakumar AT – PersonEntity: Name: NameFull: Taillon A – PersonEntity: Name: NameFull: Salhotra S – PersonEntity: Name: NameFull: Ryback B – PersonEntity: Name: NameFull: Schneider C – PersonEntity: Name: NameFull: DiGiovanni G – PersonEntity: Name: NameFull: Elbashir R – PersonEntity: Name: NameFull: Burger N – PersonEntity: Name: NameFull: Bin Munim M – PersonEntity: Name: NameFull: Lin S – PersonEntity: Name: NameFull: Puigserver P – PersonEntity: Name: NameFull: Root DE – PersonEntity: Name: NameFull: Vander Heiden MG – PersonEntity: Name: NameFull: Stegmaier K IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 06 Text: 2025 Jun 29 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |